eEF2K as an important kinase associated with cancer survival and prognosis
Nan Wang, Li-Lan Cen, Zhe Tian, Miao-Miao An, Qian Gu, Xin-Hong Zhou, Yi-He Zhang, Lucas Liu, Jun Zhang, Di Yang, Yong-Zhi Huang, Xi-Dai Long, Qian Yang · 2024
Read eEF2K as an important kinase associated with cancer survival and prognosis by Nan Wang, Li-Lan Cen, Zhe Tian, Miao-Miao An, Qian Gu, Xin-Hong Zhou, Yi-He Zhang, Lucas Liu, Jun Zhang, Di Yang, Yong-Zhi Huang, Xi-Dai Long, Qian Yang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11599947.txt.
Description
Wang and co-authors analyze a protein control enzyme called eEF2K across many cancer types, using large public datasets. The enzyme slows protein building, above all under cell stress, and it has been tied to tumor survival. Their 2024 study maps its levels, variants, and links to patient outcomes.
The enzyme played a dual role, helping or hindering tumors based on context, and its levels tracked with prognosis. Marks on its target protein were strong at three sites, which may tune protein building under stress. One mark stayed high even where the enzyme was low, hinting at backup enzymes at work. The authors suggest targeting this enzyme and its target marks as a cancer strategy worth testing.
Catalog record
| CREATOR | Nan Wang, Li-Lan Cen, Zhe Tian, Miao-Miao An, Qian Gu, Xin-Hong Zhou, Yi-He Zhang, Lucas Liu, Jun Zhang, Di Yang, Yong-Zhi Huang, Xi-Dai Long, Qian Yang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 44 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |